MedTrace Logo

Single Shot Intrathecal Analgesia in Vaginal Delivery

NCT05998551 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2023-08-21

No results posted yet for this study

Summary

Effectiveness of single shot intra-thecal analgesia in multiparous women scheduled for normal vaginal delivery

Conditions

  • Effectiveness of Single Shot Intra-thecal Analgesia in Multiparous Women Scheduled for Normal Vaginal Delivery

Interventions

DRUG

Dexmedetomidine

intrathecal injection of dexmedetomidine added to hyperbaric bupivacaine

DRUG

Fentanyl

intrathecal injection of fentanyl added to hyperbaric bupivacaine

DRUG

Bupivacaine Hcl 0.5% Inj

intrathecal injection of hyperbaric bupivacaine only

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-09-01
Completion
2023-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05998551 on ClinicalTrials.gov